LLY

724.86

-2.66%↓

NVO

122.65

-0.04%↓

MRK

125.78

+0.49%↑

ABBV

166.3

+0.95%↑

TMO

544.88

+0.67%↑

LLY

724.86

-2.66%↓

NVO

122.65

-0.04%↓

MRK

125.78

+0.49%↑

ABBV

166.3

+0.95%↑

TMO

544.88

+0.67%↑

LLY

724.86

-2.66%↓

NVO

122.65

-0.04%↓

MRK

125.78

+0.49%↑

ABBV

166.3

+0.95%↑

TMO

544.88

+0.67%↑

LLY

724.86

-2.66%↓

NVO

122.65

-0.04%↓

MRK

125.78

+0.49%↑

ABBV

166.3

+0.95%↑

TMO

544.88

+0.67%↑

LLY

724.86

-2.66%↓

NVO

122.65

-0.04%↓

MRK

125.78

+0.49%↑

ABBV

166.3

+0.95%↑

TMO

544.88

+0.67%↑

HomeStock ListBeam Therapeutics Inc

Beam Therapeutics Inc

Closed

Sector Healthcare

23.87 -1.77

Overview

Share price change

24h

Current

Min

23.65

Max

24.85

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+97.45 upside

Dividends

By Dow Jones

Next Earnings

8 May 2024

News Sentiment

By Acuity

56%

44%

203 / 274 Healthcare

Technical Score

By Trading Central

Confidence

Bearish Evidence

Beam Therapeutics Inc Chart

Related News

31 Oct 2023, 10:44 UTC

Acquisitions, Mergers, Takeovers

Beam Therapeutics to Sell Rights in Verve Licensing Deal to Lilly for $250 Million Upfront

24 Nov 2023, 12:00 UTC

Top News

Gene Editing Will Change Medicine -- and Maybe Health Investing Too -- Heard on the Street -- WSJ

31 Oct 2023, 10:29 UTC

Acquisitions, Mergers, Takeovers

Beam Therapeutics to Sell Rights in Verve Licensing Deal to Lilly for $250M Upfront

Peer Comparison

Price change

Beam Therapeutics Inc forecast

Price Target

By TipRanks

97.45% upside

12 Months Forecast

Average 48 USD  97.45%

High 75 USD

Low 27 USD

Based on 8 Wall Street analysts offering 12 month price targets forBeam Therapeutics Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

8 ratings

5

Buy

3

Hold

0

Sell

Technical Score

By Trading Central

N/A / 25.7Support & Resistance

Short Term

Bearish Evidence

Intermediate Term

Neutral Evidence

Long Term

Bearish Evidence

Sentiment

By Acuity

203 / 274 Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average